Min Lu

Company: Morphic Therapeutics

Job title: Executive Director & Head of Fibrosis

Seminars:

Targeting TGF-β Selectively to Achieve Antifibrotic Efficacy without Safety Concerns 11:00 am

• Outlining roles of TGFβ1, 2 and 3, as master regulators of fibrosis • Exploring pleiotropic effects and challenges in development, immune homeostasis, and cell cycle regulation • Selective and local inhibition of TGFβ activation may show therapeutic potential for fibrosis indicationsRead more

day: Day Two